Retina-on-a-chip offers promising perspectives for rare eye diseases

Researchers at the University of Twente and Radboudumc are developing a promising new model to enhance understanding of the ...

As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial

Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.
University of California

Making vision-restoring whole eye transplants a reality

A San Diego team is part of a major undertaking that will bring together more than 40 scientists, doctors, and industry experts hand-picked from around the country to make vision-restoring whole eye ...
New Atlas

Portable device could make functional eye transplants a reality

Despite what some movies may suggest, it's currently impossible to transplant functional, seeing human eyeballs. Scientists are taking a big step in that direction, however, with the development of an ...
Nanowerk

Nanoparticles that shrink over time deliver eye drugs to the retina without injections

Eye drop nanoparticles that shrink over time overcome the eye's natural defenses, delivering protein drugs to the retina and ...